<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=YM-348</id>
	<title>YM-348 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=YM-348"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=YM-348&amp;action=history"/>
	<updated>2026-04-25T10:03:15Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=YM-348&amp;diff=5832216&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=YM-348&amp;diff=5832216&amp;oldid=prev"/>
		<updated>2024-05-27T02:15:39Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:YM-348.svg|thumb|YM-348|right]]  {{Short description|Selective 5-HT2C receptor agonist}}&lt;br /&gt;
{{Infobox drug&lt;br /&gt;
| name      = YM-348&lt;br /&gt;
| image     = &lt;br /&gt;
| width     = &lt;br /&gt;
| alt      = &lt;br /&gt;
| caption    = &lt;br /&gt;
| legal_status  = &lt;br /&gt;
| routes_of_administration = &lt;br /&gt;
| bioavailability = &lt;br /&gt;
| protein_bound = &lt;br /&gt;
| metabolism   = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion   = &lt;br /&gt;
| CAS_number   = &lt;br /&gt;
| PubChem    = &lt;br /&gt;
| DrugBank    = &lt;br /&gt;
| ChemSpiderID  = &lt;br /&gt;
| UNII      = &lt;br /&gt;
| KEGG      = &lt;br /&gt;
| ChEBI     = &lt;br /&gt;
| ChEMBL     = &lt;br /&gt;
| synonyms    = &lt;br /&gt;
| IUPAC_name   = &lt;br /&gt;
| C= | H= | N= | O= | molecular_weight = &lt;br /&gt;
| smiles     = &lt;br /&gt;
}}&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;YM-348&amp;#039;&amp;#039;&amp;#039; is a [[chemical compound]] that acts as a selective [[5-HT2C receptor]] agonist. It has been studied for its potential applications in the treatment of various [[psychiatric disorders]] and [[neurological disorders]].&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
YM-348 functions by selectively activating the [[5-HT2C receptor]], a subtype of the [[serotonin receptor]]. The activation of this receptor is believed to influence the release of various [[neurotransmitters]] such as [[dopamine]] and [[norepinephrine]], which play a crucial role in mood regulation and other cognitive functions.&lt;br /&gt;
==Potential Applications==&lt;br /&gt;
Research has indicated that YM-348 may have therapeutic potential in the treatment of conditions such as [[depression]], [[anxiety disorders]], and [[schizophrenia]]. Its selective action on the [[5-HT2C receptor]] makes it a promising candidate for further development, as it may offer benefits with fewer side effects compared to less selective [[serotonergic drugs]].&lt;br /&gt;
==Pharmacokinetics==&lt;br /&gt;
The pharmacokinetic profile of YM-348 includes its absorption, distribution, metabolism, and excretion. However, detailed information on these parameters is not extensively documented in the available literature.&lt;br /&gt;
==Research and Development==&lt;br /&gt;
YM-348 is still under investigation, and more research is needed to fully understand its efficacy and safety profile. Clinical trials and preclinical studies are ongoing to explore its potential benefits and risks.&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[5-HT2C receptor]]&lt;br /&gt;
* [[Serotonin receptor]]&lt;br /&gt;
* [[Psychiatric disorders]]&lt;br /&gt;
* [[Neurological disorders]]&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
[[Category:Serotonin receptor agonists]]&lt;br /&gt;
[[Category:Experimental drugs]]&lt;br /&gt;
[[Category:Psychiatric drugs]]&lt;br /&gt;
[[Category:Neurological drugs]]&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>